New York State Common Retirement Fund
CTKB icon

New York State Common Retirement Fund’s Cytek Biosciences CTKB Stock Holding History

New York State Common Retirement Fund’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Hold
34,922
– – ﹤0.01% 2479
2026
Q1 		$153K Hold
34,922
– – ﹤0.01% 2342
2025
Q4 		$176K Sell
34,922
-296,268
-89% -$1.38M ﹤0.01% 2346
2025
Q3 		$1.15M Sell
331,190
-1,757,200
-84% -$6.6M ﹤0.01% 1629
2025
Q2 		$7.1M Hold
2,088,390
– – 0.01% 908
2025
Q1 		$8.37M Hold
2,088,390
– – 0.01% 796
2024
Q4 		$13.6M Hold
2,088,390
– – 0.02% 629
2024
Q3 		$11.6M Sell
2,088,390
-860,618
-29% -$4.88M 0.02% 713
2024
Q2 		$16.5M Buy
2,949,008
+1,022
+0% +$6.14K 0.02% 589
2024
Q1 		$19.8M Hold
2,947,986
– – 0.03% 534
2023
Q4 		$26.9M Buy
2,947,986
+599,971
+26% +$3.78M 0.04% 410
2023
Q3 		$13M Buy
2,348,015
+700,701
+43% +$5.62M 0.02% 703
2023
Q2 		$14.1M Buy
1,647,314
+268,029
+19% +$2.4M 0.02% 721
2023
Q1 		$12.7M Buy
1,379,285
+552,162
+67% +$5.94M 0.02% 762
2022
Q4 		$8.44M Buy
827,123
+194,116
+31% +$2.61M 0.01% 956
2022
Q3 		$9.32M Buy
633,007
+561,521
+785% +$7.29M 0.01% 881
2022
Q2 		$767K Buy
71,486
+532
+0.7% +$5.29K ﹤0.01% 2160
2022
Q1 		$765K Buy
70,954
+60,125
+555% +$812K ﹤0.01% 2232
2021
Q4 		$177K Buy
10,829
+5,229
+93% +$110K ﹤0.01% 2915
2021
Q3 		$120K Buy
+5,600
New +$132K ﹤0.01% 3082

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

New York State Common Retirement Fund's CTKB Position: Q2 2026 in Review

New York State Common Retirement Fund held its Cytek Biosciences (CTKB) position steady in Q2 2026 at 34,922 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

New York State Common Retirement Fund first reported a position in CTKB in Q3 2021 and has held it in 20 quarters since. The position peaked at $26.9M in Q4 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • New York State Common Retirement Fund held 34,922 shares of Cytek Biosciences worth $155K as of Q2 2026.
  • New York State Common Retirement Fund left its Cytek Biosciences share count unchanged in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2479 holding.
  • New York State Common Retirement Fund first reported a position in Cytek Biosciences in Q3 2021 and has held it in 20 quarters since.
  • New York State Common Retirement Fund's Cytek Biosciences position peaked at $26.9M in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.